[How should one anticipate the assessment of the public health benefit of new medicines?].
Massol
Jacques
J
Institut Phisquare, Fondation Transplantation, Besançon, France. jacques.massol@univ-fcomte.fr
Puech
Alain
A
Boissel
Jean-Pierre
JP
D003256:Community Participation; D004345:Drug Industry; D004358:Drug Therapy / Q000191:economics / Q000592:standards* / Q000639:trends*; D005602:France; D006801:Humans; D011634:Public Health / Q000592:standards / Q000639:trends*; D012051:Reimbursement Mechanisms